Adage Capital Partners Gp, L.L's Net Worth
Adage Capital Partners Gp, L.L's net worth is estimated to be at least $581,299,859.72 as of 11/09/2024. CoreStreet's estimation of Adage Capital Partners Gp, L.L's net worth is based on their sale of stock and current holding of stock.
Adage Capital Partners Gp, L.L is Major Shareholder at Royalty Pharma plc. They have executed at least 9 trades of stock as per SEC Form 4 filings. Their most recent trade was for 7,301,050 units of RPRX stock on 12/18/2020. Their biggest sale was on 12/18/2020 when they sold 7,301,050 units of Royalty Pharma plc stock for $320,662,116.00. They typically trade 3 times per year.
Total value of insider buys:
- $90,574,991.00
Total value of insider sells:
- $490,724,868.72
Most recent insider trade:
- Dec. 18, 2020
Adage Capital Partners Gp, L.L's Insider Trading History
| Royalty Pharma plc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 18, 2020 | Major Shareholder | 7,301,050 | $43.92 | Sell | $320,662,116.00 |
June 18, 2020 | Major Shareholder | 3,000,000 | $28.00 | Buy | $84,000,000.00 |
| AMCI Acquisition Corp II | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 2, 2020 | Major Shareholder | 300,000 | $11.67 | Sell | $3,501,000.00 |
| Calithera Biosciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 28, 2017 | Major Shareholder | 576,000 | $15.64 | Sell | $9,008,640.00 |
March 22, 2017 | Major Shareholder | 487,804 | $10.25 | Buy | $4,999,991.00 |
Nov. 16, 2016 | Major Shareholder | 500,000 | $3.15 | Buy | $1,575,000.00 |
| Puma Biotechnology Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 12, 2017 | Major Shareholder | 247,260 | $80.32 | Sell | $19,859,923.20 |
June 5, 2017 | Major Shareholder | 507,128 | $87.84 | Sell | $44,546,123.52 |
May 26, 2017 | Major Shareholder | 1,235,700 | $75.38 | Sell | $93,147,066.00 |